Ron Insana: For the first time ever, a recession could end with a bear market

With all due respect to the late, and great, Tom Petty, when it comes to today's stock market averages, it's "the weighting that is the hardest part." What's odd about th...

Stocks making the biggest moves midday: Nike, Tesla, Stitch Fix, Peloton, Nikola & more

Nike — Shares of the apparel giant surged 8.3% on Wednesday after the company reported better-than-expected results for its fiscal first quarter. But both are a few years...

Stocks making the biggest moves in the premarket: Nike, General Mills, J&J, KKR, KB Home & more

General Mills (GIS) – The food producer earned $1.00 per share for its latest quarter, beating estimates by 13 cents a share. General Mills also announced a 4% hike in it...

Johnson & Johnson enters late-stage trial testing its coronavirus vaccine

The Latest: China lifts pandemic bar on entry by foreigners

Asian shares fall as caution sets in after Wall St retreat

Dow closes more than 500 points lower as tech pressure mounts, Apple slides 4%

Stocks making the biggest moves in the premarket: Target, Lowe's, McKesson, Harley-Davidson & more

Johnson & Johnson to stop selling talc-based baby powder in U.S., Canada

Stocks making the biggest moves after hours: Urban Outfitters, Moderna, Johnson & Johnson and more

The timeline on some of the most promising Covid-19 vaccine and treatments under development right now

Pfizer begins human testing for experimental coronavirus vaccine in the US

Emergent Biosolutions CEO on Trump's wishes to develop a vaccine by year end 'Nobody can guarantee anything'

Trump says he believes there will be a coronavirus vaccine 'by the end of the year'

Inovio Pharmaceuticals expects to finish recruiting coronavirus vaccine volunteers by the end of April, CEO says

For investors banking on dividends, the 'pain has just begun'

J&J raises dividend but cuts 2020 earnings outlook over coronavirus outbreak; shares rise

J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well

Three stocks could determine the next move for the market this earnings season

Stocks making the biggest moves midday: Amazon, Roku, Tesla, JPMorgan and more

Watch live: Coronavirus task force holds briefing as outbreak eases in some hard-hit areas

Banks and health care companies will report earnings, but virus updates will matter most in week ahead

Phase 2 of coronavirus vaccine human trials may begin in spring, Moderna chairman says

5 things to know before the stock market opens Monday

Stocks making the biggest moves in the premarket: J&J, Sanofi, Regeneron, La-Z-Boy, Apple & more

Here's what happened to the stock market on Monday

Johnson & Johnson stock jumps 8% after it says human testing of its coronavirus vaccine to begin by September

If you see an earnings estimate, it's probably wrong, given ongoing pandemic uncertainty

J&J hopes to start human trials for coronavirus vaccine in November

Closely watched opioid trial in New York postponed due to coronavirus

Health care can still climb back to all-time highs, chart suggests here are the stocks traders are buying

Stocks making the biggest moves premarket: Zoom Video, American Eagle, FireEye, Moderna & more

Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case

J&J scientific officer 'pretty confident' they can create coronavirus vaccine as outbreak widens

Johnson & Johnson beats Wall Street expectations on profit, misses on revenue

Stocks making the biggest moves premarket: J&J, Moderna, Netflix, Boeing, IBM, Xerox & more

First FANG stock report, home sales, J&J earnings: 3 things to watch for on Wednesday

Stocks making the biggest moves premarket: Boeing, Pfizer, Tesla, Pier 1, J&J, T-Mobile & more

One options trader just made a $2 million bet on Johnson & Johnson. Here's why it could work out

Oklahoma judge reduces J&J order in opioid lawsuit by $107M

New York judge sets opioid crisis trial for January

Johnson & Johnson: New Lab Tests Didnt Find Asbestos In Recalled Baby Powder

Target removes all 22-ounce J&J baby powder from its shelves

October brings losses for short sellers in U.S. opioid-related shares

Drug companies reach settlement, averting first federal opioid trial

Johnson & Johnson stock falls after asbestos found in baby powder

Johnson & Johnson recalls baby powder due to asbestos concerns

Johnson & Johnson to recall single lot of baby powder as FDA finds traces of asbestos

Drug companies may pay $50 billion for their role in opioid crisis

Johnson & Johnson has to pay $8 billion, jury decides

Johnson & Johnson reaches $20.4M settlement agreement

Johnson & Johnson ordered to pay $572 million in Okla. opioid trial

Opioid trial judge could deliver biggest judgment in US history

Okla. urges judge to deliver $17.2B verdict in opioid case

Johnson & Johnson wants Oklahoma opioid case tossed

Oklahoma rests case in opioid trial against drugmaker Johnson & Johnson

Oklahoma attorney slams Johnson and Johnson witness in opioid trial

On this day: October 5